Skip to main content

Post-IPO Equity Health Care Companies

Explore 434 health care startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
434
Total Funding
$2.0B
Avg Funding
$81.8M
Cities
21

Export 434 Post-IPO Equity Health Care Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
$1.8M
raised

Mountain Valley MD Holdings is in the final stages of proving up a low-cost, low-risk exploration project.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Louisville, United States
$74.4M
raised

Charlotte's Web develops and distributes hemp-derived cannabidiol wellness products.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Melbourne, Australia
$57.0M
raised

4DMedical is a global medical technology company, revolutionizing respiratory imaging and ventilation analysis for lung diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$3.0M
raised

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$100.0M
raised

Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$75.0M
raised

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$20.0M
raised

Lumos Diagnostics provides point-of-care diagnostic solutions enabling healthcare professionals to diagnose conditions accurately.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Lund, Sweden
$967K
raised

Hamlet BioPharma is a pharmaceutical company with strong links to research.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Branford, United States
$31.0M
raised

Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Helsingborg, Sweden
$2.8M
raised

Qlife is a Danish medical technology company that develops an innovative medical technology platform.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$60.0M
raised

Ovid Therapeutic's purpose is to solve intractable medical problems.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Waltham, United States
$719.0M
raised

Dianthus Therapeutics is a biotech company developing new treatments for serious autoimmune diseases using a more targeted approach.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

New Haven, United States
$8.0M
raised

BioXcel Therapeutics is a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$589K
raised

Lancaster Resources is a dynamic exploration company dedicated to the emerging energy sector transition opportunity.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$85.0M
raised

Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Charlestown, United States
$240.0M
raised

Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$1.1M
raised

GenFlow Biosciences is a biotech company that develops gene therapies for slow or reverse aging in humans and animals.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Singapore, Singapore
$3.8M
raised

EUDA Health is a health technology company that offers healthcare and wellness service.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Chicago, United States
$30.0M
raised

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

Mar 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Freehold, United States
$9.8M
raised

Avalon GloboCare is a biotech company that develops diagnostics, cellular therapies, along with health tech products.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 434 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Altrincham, United Kingdom
$200.0M
raised

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Wayne, United States
$200.0M
raised

Palvella Therapeutics focuses on relentlessly and selflessly serving abandoned patient populations with therapies.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Moncton, Canada
$47.6M
raised

OrganiGram is a producer and distributor of medical and recreational cannabis.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Victoria, Canada
$63.2M
raised

Eupraxia is a clinical-stage biotech company developing locally delivered, extended-release alternatives to currently approved drugs.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Morristown, United States
$12.0M
raised

Cingulate Therapeutics uses a unique combination of delivery technology and proven medications that creates an unmatched release profile.

Feb 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 126 to 150 of 434 companies

Ready to Connect with Post-IPO Equity Health Care Startups?

Get verified founder emails, funding details, and company data for 434 post-ipo equity health care companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked